AB&B BIO-TECH-B

2627
29.3200.00% ( 0.000 )
Delay Suspended: Nov 17, 09:29:26

Financials

Q2 FY2025 Earnings

Financial report interval: 2025.03.30 - 2025.06.30

Overview: AB&B BIO-TECH-B(02627) the Revenue is 77.48 M (+980.8%);the EBIT is -33.05 M (+66.02%);the EPS is -0.104 (+62.29%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.08B980.75%
----
----
EBIT
-0.03B66.02%
----
----
EPS
-0.104162.29%
----
----

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly